Viewing Study NCT01191892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-02-23 @ 12:20 PM
Study NCT ID: NCT01191892
Status: COMPLETED
Last Update Posted: 2019-05-16
First Post: 2010-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Sponsor: Cardiff University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None Transitional Cell Cancer of the Renal Pelvis and Ureter View
None Ureter Cancer View
None Urethral Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic transitional cell cancer of the renal pelvis and ureter View
None regional transitional cell cancer of the renal pelvis and ureter View
None transitional cell carcinoma of the bladder View
None stage III bladder cancer View
None stage IV bladder cancer View
None anterior urethral cancer View
None posterior urethral cancer View
None urethral cancer associated with invasive bladder cancer View
None ureter cancer View